{"id":"https://openalex.org/W2944720152","doi":"https://doi.org/10.1080/21645515.2019.1616499","title":"Immunogenicity of a protective intradermal DNA vaccine against lassa virus in cynomolgus macaques","display_name":"Immunogenicity of a protective intradermal DNA vaccine against lassa virus in cynomolgus macaques","publication_year":2019,"publication_date":"2019-05-09","ids":{"openalex":"https://openalex.org/W2944720152","doi":"https://doi.org/10.1080/21645515.2019.1616499","mag":"2944720152","pmid":"https://pubmed.ncbi.nlm.nih.gov/31071008","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6773375"},"language":"en","primary_location":{"id":"doi:10.1080/21645515.2019.1616499","doi":"https://doi.org/10.1080/21645515.2019.1616499","is_oa":true,"landing_page_url":"https://doi.org/10.1080/21645515.2019.1616499","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/21645515.2019.1616499?needAccess=true","source":{"id":"https://openalex.org/S2483136528","display_name":"Human Vaccines & Immunotherapeutics","issn_l":"2164-5515","issn":["2164-5515","2164-554X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Vaccines & Immunotherapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/21645515.2019.1616499?needAccess=true","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Jingjing Jiang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jingjing Jiang","raw_affiliation_strings":["Research & Development, Inovio Pharmaceuticals Inc , Plymouth Meeting, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Inovio Pharmaceuticals Inc , Plymouth Meeting, PA, USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050242769","display_name":"Preeti Banglore","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Preeti Banglore","raw_affiliation_strings":["Research & Development, Inovio Pharmaceuticals Inc , Plymouth Meeting, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Inovio Pharmaceuticals Inc , Plymouth Meeting, PA, USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075535603","display_name":"Kathleen A. Cashman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801122164","display_name":"United States Army Medical Research Institute of Infectious Diseases","ror":"https://ror.org/01pveve47","country_code":"US","type":"facility","lineage":["https://openalex.org/I106965489","https://openalex.org/I1304082316","https://openalex.org/I1330347796","https://openalex.org/I2801122164","https://openalex.org/I2802581893"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathleen A. Cashman","raw_affiliation_strings":["Virology Division, United States Army Medical Research Institute of Infectious Diseases , Fort Detrick, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virology Division, United States Army Medical Research Institute of Infectious Diseases , Fort Detrick, MD, USA","institution_ids":["https://openalex.org/I2801122164"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022884834","display_name":"Connie S. Schmaljohn","orcid":"https://orcid.org/0000-0001-8852-5482","observed_orcids":["https://orcid.org/0000-0001-8852-5482","https://orcid.org/0000-0002-8834-0784"]},"institutions":[{"id":"https://openalex.org/I2801122164","display_name":"United States Army Medical Research Institute of Infectious Diseases","ror":"https://ror.org/01pveve47","country_code":"US","type":"facility","lineage":["https://openalex.org/I106965489","https://openalex.org/I1304082316","https://openalex.org/I1330347796","https://openalex.org/I2801122164","https://openalex.org/I2802581893"]},{"id":"https://openalex.org/I4210088792","display_name":"United States Army","ror":"https://ror.org/00afsp483","country_code":"US","type":"government","lineage":["https://openalex.org/I1304082316","https://openalex.org/I1330347796","https://openalex.org/I4210088792"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Connie S. Schmaljohn","raw_affiliation_strings":["Office of the Chief Scientists, U.S. Army Medical Research Institute of Infectious Diseases , Fort Detrick, MD, USA"],"raw_orcid":"https://orcid.org/0000-0002-8834-0784","affiliations":[{"raw_affiliation_string":"Office of the Chief Scientists, U.S. Army Medical Research Institute of Infectious Diseases , Fort Detrick, MD, USA","institution_ids":["https://openalex.org/I2801122164","https://openalex.org/I4210088792"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008018388","display_name":"Katherine Schultheis","orcid":"https://orcid.org/0000-0001-9232-1888","observed_orcids":["https://orcid.org/0000-0001-9232-1888"]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katherine Schultheis","raw_affiliation_strings":["Research & Development, Inovio Pharmaceuticals Inc , Plymouth Meeting, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Inovio Pharmaceuticals Inc , Plymouth Meeting, PA, USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005082288","display_name":"Holly M. Pugh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Holly Pugh","raw_affiliation_strings":["Research & Development, Inovio Pharmaceuticals Inc , Plymouth Meeting, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Inovio Pharmaceuticals Inc , Plymouth Meeting, PA, USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022065601","display_name":"Jacklyn Nguyen","orcid":"https://orcid.org/0000-0003-3289-2130","observed_orcids":["https://orcid.org/0000-0003-3289-2130"]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacklyn Nguyen","raw_affiliation_strings":["Research & Development, Inovio Pharmaceuticals Inc , Plymouth Meeting, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Inovio Pharmaceuticals Inc , Plymouth Meeting, PA, USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015488396","display_name":"Laurent M. P. F. Humeau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laurent M. Humeau","raw_affiliation_strings":["Research & Development, Inovio Pharmaceuticals Inc , Plymouth Meeting, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Inovio Pharmaceuticals Inc , Plymouth Meeting, PA, USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062840115","display_name":"Kate E. Broderick","orcid":"https://orcid.org/0000-0003-2682-2363","observed_orcids":["https://orcid.org/0000-0003-2682-2363"]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kate E. Broderick","raw_affiliation_strings":["Research & Development, Inovio Pharmaceuticals Inc , Plymouth Meeting, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Inovio Pharmaceuticals Inc , Plymouth Meeting, PA, USA","institution_ids":["https://openalex.org/I4210137215"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067942048","display_name":"Stephanie J. Ramos","orcid":"https://orcid.org/0000-0002-5326-4937","observed_orcids":["https://orcid.org/0000-0002-5326-4937"]},"institutions":[{"id":"https://openalex.org/I4210137215","display_name":"Inovio Pharmaceuticals (United States)","ror":"https://ror.org/042s6y882","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137215"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Stephanie J. Ramos","raw_affiliation_strings":["Research & Development, Inovio Pharmaceuticals Inc , Plymouth Meeting, PA, USA"],"raw_orcid":"https://orcid.org/0000-0002-5326-4937","affiliations":[{"raw_affiliation_string":"Research & Development, Inovio Pharmaceuticals Inc , Plymouth Meeting, PA, USA","institution_ids":["https://openalex.org/I4210137215"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5067942048"],"corresponding_institution_ids":["https://openalex.org/I4210137215"],"apc_list":{"value":2895,"currency":"EUR","value_usd":3175},"apc_paid":{"value":2895,"currency":"EUR","value_usd":3175},"fwci":3.691,"has_fulltext":false,"cited_by_count":35,"citation_normalized_percentile":{"value":0.93391827,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"15","issue":"9","first_page":"2066","last_page":"2074"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12047","display_name":"Viral Infections and Vectors","score":0.9663000106811523,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12047","display_name":"Viral Infections and Vectors","score":0.9663000106811523,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11581","display_name":"Viral Infections and Outbreaks Research","score":0.025100000202655792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11767","display_name":"Poxvirus research and outbreaks","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lassa-virus","display_name":"Lassa virus","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dna-vaccine","display_name":"DNA vaccine","score":0.9399999976158142},{"id":"https://openalex.org/keywords/intradermal-vaccination","display_name":"intradermal vaccination","score":0.8270000219345093},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.7919999957084656},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.8529999852180481},{"id":"https://openalex.org/keywords/t-cell-response","display_name":"T cell response","score":0.9169999957084656},{"id":"https://openalex.org/keywords/pseudovirus-neutralization","display_name":"pseudovirus neutralization","score":0.6840000152587891},{"id":"https://openalex.org/keywords/cynomolgus-macaques","display_name":"cynomolgus macaques","score":0.7929999828338623},{"id":"https://openalex.org/keywords/lassa-fever","display_name":"Lassa fever","score":0.609000027179718}],"concepts":[{"id":"https://openalex.org/C2777427142","wikidata":"https://www.wikidata.org/wiki/Q24719561","display_name":"Lassa virus","level":3,"score":0.914069414138794},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.8234908580780029},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.7450687885284424},{"id":"https://openalex.org/C2780023225","wikidata":"https://www.wikidata.org/wiki/Q706845","display_name":"Lassa fever","level":3,"score":0.6990134716033936},{"id":"https://openalex.org/C2779574689","wikidata":"https://www.wikidata.org/wiki/Q2368907","display_name":"Arenavirus","level":5,"score":0.5728583335876465},{"id":"https://openalex.org/C3018567284","wikidata":"https://www.wikidata.org/wiki/Q1044","display_name":"Sierra leone","level":2,"score":0.565708577632904},{"id":"https://openalex.org/C167508917","wikidata":"https://www.wikidata.org/wiki/Q578537","display_name":"DNA vaccination","level":4,"score":0.5383720397949219},{"id":"https://openalex.org/C2779053233","wikidata":"https://www.wikidata.org/wiki/Q731235","display_name":"ELISPOT","level":4,"score":0.537070095539093},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5354070663452148},{"id":"https://openalex.org/C2776185481","wikidata":"https://www.wikidata.org/wiki/Q1425304","display_name":"Viremia","level":3,"score":0.5039059519767761},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.47813355922698975},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.475831538438797},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4616604447364807},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4072974920272827},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.406019002199173},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.3915199935436249},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.26738256216049194},{"id":"https://openalex.org/C2780801004","wikidata":"https://www.wikidata.org/wiki/Q1415366","display_name":"Immunization","level":3,"score":0.14087703824043274},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.09252235293388367},{"id":"https://openalex.org/C2780190958","wikidata":"https://www.wikidata.org/wiki/Q1878776","display_name":"Lymphocytic choriomeningitis","level":4,"score":0.06530532240867615},{"id":"https://openalex.org/C47768531","wikidata":"https://www.wikidata.org/wiki/Q1127188","display_name":"Development economics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000071497","descriptor_name":"Immunogenicity, Vaccine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000914","descriptor_name":"Antibodies, Viral","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000914","descriptor_name":"Antibodies, Viral","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006168","descriptor_name":"Guinea Pigs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007111","descriptor_name":"Immunity, Cellular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007114","descriptor_name":"Immunization","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D007271","descriptor_name":"Injections, Intradermal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007835","descriptor_name":"Lassa Fever","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D007836","descriptor_name":"Lassa virus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008252","descriptor_name":"Macaca fascicularis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014759","descriptor_name":"Viral Envelope Proteins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D014765","descriptor_name":"Viral Vaccines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014765","descriptor_name":"Viral Vaccines","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D014766","descriptor_name":"Viremia","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D019444","descriptor_name":"Vaccines, DNA","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019444","descriptor_name":"Vaccines, DNA","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D056724","descriptor_name":"Immunity, Humoral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1080/21645515.2019.1616499","doi":"https://doi.org/10.1080/21645515.2019.1616499","is_oa":true,"landing_page_url":"https://doi.org/10.1080/21645515.2019.1616499","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/21645515.2019.1616499?needAccess=true","source":{"id":"https://openalex.org/S2483136528","display_name":"Human Vaccines & Immunotherapeutics","issn_l":"2164-5515","issn":["2164-5515","2164-554X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Vaccines & Immunotherapeutics","raw_type":"journal-article"},{"id":"pmid:31071008","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31071008","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human vaccines & immunotherapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6773375","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6773375/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hum Vaccin Immunother","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:1b1f1038310b49d6b16a6be5bb6f7c01","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/1b1f1038310b49d6b16a6be5bb6f7c01","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Human Vaccines & Immunotherapeutics, Vol 15, Iss 9, Pp 2066-2074 (2019)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1080/21645515.2019.1616499","doi":"https://doi.org/10.1080/21645515.2019.1616499","is_oa":true,"landing_page_url":"https://doi.org/10.1080/21645515.2019.1616499","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/21645515.2019.1616499?needAccess=true","source":{"id":"https://openalex.org/S2483136528","display_name":"Human Vaccines & Immunotherapeutics","issn_l":"2164-5515","issn":["2164-5515","2164-554X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Vaccines & Immunotherapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5733154742","display_name":null,"funder_award_id":"W81XWH-11-C-0051","funder_id":"https://openalex.org/F4320338280","funder_display_name":"Medical Research and Materiel Command"}],"funders":[{"id":"https://openalex.org/F4320316471","display_name":"INOVIO Pharmaceuticals","ror":"https://ror.org/042s6y882"},{"id":"https://openalex.org/F4320338280","display_name":"Medical Research and Materiel Command","ror":"https://ror.org/03cd02q50"}],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2944720152.pdf"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W1743140698","https://openalex.org/W1927179988","https://openalex.org/W1951091454","https://openalex.org/W1964555202","https://openalex.org/W2039546121","https://openalex.org/W2052649413","https://openalex.org/W2053855507","https://openalex.org/W2058150819","https://openalex.org/W2061829061","https://openalex.org/W2064154023","https://openalex.org/W2067775399","https://openalex.org/W2077072174","https://openalex.org/W2092721627","https://openalex.org/W2099137686","https://openalex.org/W2105054327","https://openalex.org/W2112216576","https://openalex.org/W2119995018","https://openalex.org/W2124577002","https://openalex.org/W2128471759","https://openalex.org/W2136419495","https://openalex.org/W2172157105","https://openalex.org/W2322725798","https://openalex.org/W2376309928","https://openalex.org/W2514887832","https://openalex.org/W2582497730","https://openalex.org/W2750787946","https://openalex.org/W2761417170","https://openalex.org/W2762677063","https://openalex.org/W2765570002","https://openalex.org/W2788066505","https://openalex.org/W2795067964","https://openalex.org/W2797036055","https://openalex.org/W2886610362","https://openalex.org/W2899417061"],"related_works":["https://openalex.org/W2765570002","https://openalex.org/W2977465302","https://openalex.org/W4404795762","https://openalex.org/W2039546121","https://openalex.org/W2920023727","https://openalex.org/W3134778695","https://openalex.org/W4286250577","https://openalex.org/W3008257677","https://openalex.org/W4404446657","https://openalex.org/W2077072174"],"abstract_inverted_index":{"Lassa":[0,35],"virus":[1,7],"(LASV)":[2],"is":[3,29,195],"a":[4,83,94,98,169,215],"hemorrhagic":[5],"fever":[6,36],"of":[8,15,40,45,71,131,197,220],"the":[9,52,79,128,132,158,191,207],"Arenaviridae":[10],"family":[11],"with":[12,74,151],"high":[13],"rates":[14],"mortality":[16],"and":[17,22,34,48,110,118,163,203,206,222],"co-morbidities,":[18],"including":[19],"chronic":[20],"seizures":[21],"permanent":[23],"bilateral":[24],"or":[25],"unilateral":[26],"deafness.":[27],"LASV":[28,69,100,122,133,160],"endemic":[30],"in":[31,43,57,61,64,136,144,168,210,226],"West":[32],"Africa":[33],"accounts":[37],"for":[38,82],"10-16%":[39],"hospitalizations":[41],"annually":[42],"parts":[44],"Sierra":[46],"Leone":[47],"Liberia":[49],"according":[50],"to":[51,85,157,217],"CDC.":[53],"An":[54],"ongoing":[55],"outbreak":[56],"Nigeria":[58],"has":[59],"resulted":[60],"144":[62],"deaths":[63],"568":[65],"cases":[66],"confirmed":[67],"as":[68,70,181],"November":[72],"2018,":[73],"many":[75],"more":[76],"suspected,":[77],"highlighting":[78],"urgent":[80],"need":[81],"vaccine":[84,96,135,194],"prevent":[86],"this":[87,211],"severe":[88],"disease.":[89],"We":[90],"previously":[91],"reported":[92],"on":[93,127],"DNA":[95,134,193],"encoding":[97],"codon-optimized":[99],"glycoprotein":[101,161],"precursor":[102],"gene,":[103],"pLASV-GPC,":[104],"which":[105],"completely":[106],"protects":[107],"Guinea":[108],"pigs":[109],"nonhuman":[111],"primates":[112],"(NHPs)":[113],"against":[114],"viremia,":[115],"clinical":[116,228],"disease,":[117],"death":[119],"following":[120],"lethal":[121],"challenge.":[123],"Herein":[124],"we":[125],"report":[126],"immunogenicity":[129],"profile":[130],"protected":[137],"NHPs.":[138],"Antigen-specific":[139],"binding":[140],"antibodies":[141,154],"were":[142],"generated":[143],"100%":[145],"(6/6)":[146],"NHPs":[147,174],"after":[148],"two":[149],"immunizations":[150],"pLASV-GPC.":[152],"These":[153,187],"bound":[155],"predominantly":[156],"assembled":[159],"complex":[162],"had":[164],"robust":[165],"neutralizing":[166],"activity":[167],"pseudovirus":[170],"assay.":[171,186],"pLASV-GPC":[172,192],"DNA-immunized":[173],"(5/6)":[175],"also":[176],"developed":[177,209],"T":[178,201],"cell":[179,202],"responses":[180,225],"measured":[182],"by":[183],"IFN\u03b3":[184],"ELISpot":[185],"results":[188],"revealed":[189],"that":[190],"capable":[196],"generating":[198],"functional,":[199],"LASV-specific":[200],"antibody":[204],"responses,":[205],"assays":[208],"study":[212],"will":[213],"provide":[214],"framework":[216],"identify":[218],"correlates":[219],"protection":[221],"characterize":[223],"immune":[224],"future":[227],"trials.":[229]},"counts_by_year":[{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":8}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2019-05-16T00:00:00"}